Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_assertion type Assertion NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_head.
- NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_assertion description "[We undertook the current study with untreated breast cancer to (1) role the variations in the plasma levels of cfDNA and the size distribution in early stage, (2) determine the frequency in plasma of methylation of three candidate genes, RASSF1A, MAL, and SFRP1, and (3) to determine whether detection of cfDNA variations and methylation changes in plasma might have specific clinical utility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_provenance.
- NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_assertion evidence source_evidence_literature NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_provenance.
- NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_assertion SIO_000772 23011155 NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_provenance.
- NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_assertion wasDerivedFrom befree-20140225 NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_provenance.
- NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_assertion wasGeneratedBy ECO_0000203 NP805599.RAFp5sIF3X4Psu7_QqhB8aT6aQCFeYYZXMw6I2Q8evRrE130_provenance.